___

• 1. Blade J, Kyle RA, Greipp PR. Presenting features and prognosis in 72 patients with multiple myeloma who were younger than 40 years. Br J Haematol. 1196;93:345-51..
• 2. Nakazato T, Suzuki K, Mihara A, Sanada Y, Kakimoto T. Refractory plasmablastic type myeloma with multiple extramedullary plasmacytomas and massive myelomatous effusion: remarkable response with a combination of thalidomide and dexamethasone. Intern Med. 2009;48: 1827-32.
• 3. Kintzer JS Jr, Rosenow EC, Kyle RA. Thoracic and pulmonary abnormalities in multiple myeloma: a review of 958 cases. Arch Intern Med. 1978;138;727-30.
• 4. Uskül BT, Türker H, Emre Turan F, Unal Bayraktar O, Melikoglu A, Tahaoğlu C et al. Pleural effusion as the first sign of multiple myeloma. Tuberk Toraks. 2008;56:439-42.
• 5. Kamble R, Wilson CS, Fassas A. Malignant pleural effusion of myeloma: prognostic factors and outcome. Leuk Lymphoma. 20085;46:1137-42.
• 6. Cho Y-U et al. Myelomatous Pleural Effusion: A case series in a single institution and literature review. Korean J Lab Med. 2011;31:225-30.